Inflammation and cardiovascular risk
نویسندگان
چکیده
منابع مشابه
Obesity, inflammation, and cardiovascular risk.
Obesity, a highly prevalent condition, is heterogeneous with regard to its impact on cardiovascular disease (CVD) risk. Epidemiological observations and metabolic investigations have consistently demonstrated that the accumulation of excess visceral fat is related to an increased risk of CVD as well as several metabolic and inflammatory perturbations. In the past decade, data from several studi...
متن کاملInflammation as a cardiovascular risk factor.
Inflammation occurs in the vasculature as a response to injury, lipid peroxidation, and perhaps infection. Various risk factors, including hypertension, diabetes, and smoking, are amplified by the harmful effects of oxidized low-density-lipoprotein cholesterol, initiating a chronic inflammatory reaction, the result of which is a vulnerable plaque, prone to rupture and thrombosis. Epidemiologica...
متن کاملGlycosylation Signatures of Inflammation Identify Cardiovascular Risk
Robust experimental and observational data implicate inflammation as a fundamental driver in the pathogenesis of atherosclerotic cardiovascular disease (CVD). Chronic inflammatory diseases provide unique opportunities to gain insight into mechanisms of accelerated atherogenesis in broader populations. Patients with diseases such as psoriasis and rheumatoid arthritis that are characterized by ch...
متن کاملDoes inflammation influence cardiovascular risk factor modification?
tables or figures and should relate solely to an article published in Circulation within the preceding 12 weeks. Authors of letters selected for publication will receive prepublication proofs, and authors of the article cited in the letter will be invited to reply. Replies must be signed by all authors listed in the original publication. Please submit three typewritten, double-spaced copies of ...
متن کاملLipoprotein-Associated Phospholipase A2, Vascular Inflammation and Cardiovascular Risk Prediction
Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) is a marker of inflammation that plays a critical role in atherogenesis; its inhibition may have antiatherogenic effects. Studies from the West of Scotland Coronary Prevention Study (WOSCOPS), Monitoring Trends and Determinants in Cardiovascular Diseases (MONICA) and Rotterdam cohorts have shown that Lp-PLA2 is an independent predict...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Future Cardiology
سال: 2009
ISSN: 1479-6678,1744-8298
DOI: 10.2217/14796678.5.2.121